No two blood groups are medically forbidden from marrying. The idea that certain blood types make a couple incompatible comes from a real medical concern, Rh factor incompatibility, but the risk it poses has been almost entirely eliminated by a routine injection given during pregnancy. The pairing most often flagged is an Rh-negative woman with an Rh-positive man, because their children can develop a condition called hemolytic disease of the newborn. Yet even this combination is manageable with standard prenatal care, and no medical authority anywhere in the world advises against marriage based on ABO or Rh blood type alone.
Where the “Cannot Marry” Idea Comes From
The question usually traces back to concerns about Rh factor, a protein found on the surface of red blood cells. If you have it, you are Rh-positive; if you lack it, you are Rh-negative. Roughly 85 percent of people worldwide are Rh-positive, though the proportion varies across populations. Problems can arise when an Rh-negative woman carries an Rh-positive baby, a situation that occurs when the father is Rh-positive. During pregnancy or delivery, small amounts of the baby’s blood can cross into the mother’s circulation. Her immune system recognizes the Rh protein as foreign and produces antibodies against it. This process, called Rh sensitization, is usually harmless during a first pregnancy. But in subsequent pregnancies with another Rh-positive baby, those antibodies can cross the placenta and attack the baby’s red blood cells, causing anemia that ranges from mild jaundice to life-threatening complications.
This condition was first recognized as a single clinical entity in 1932, and by 1941 researchers had worked out that it resulted from the mother’s immune system reacting against a blood group factor inherited from the father.1Pediatrics. Protection Against Rh Sensitization and Prevention of Erythroblastosis Fetalis For decades before a preventive treatment existed, Rh incompatibility caused thousands of infant deaths and stillbirths each year. That historical severity is the root of the fear that some blood types should never mix in a marriage.
How Rh Incompatibility Is Prevented Today
The breakthrough came with Rh immunoglobulin, sold under brand names like RhoGAM. This injection works by clearing any of the baby’s Rh-positive red blood cells from the mother’s circulation before her immune system mounts a lasting response. It is given to all Rh-negative pregnant women at around 28 weeks, with a second dose within 72 hours after delivery if the newborn turns out to be Rh-positive. This protocol drops the risk of sensitization from roughly 13 to 16 percent down to about 0.1 to 0.2 percent.2CrossRef API / Journal of Patient Safety and Risk Management. Consequences of erroneous reporting and interpretation of positive antibody screen in Rhesus (Rh) negative pregnancy That is a near-total elimination of the problem.
Rh immunoglobulin is widely available in hospitals and clinics around the world. It is also given after miscarriages, ectopic pregnancies, amniocentesis, and any other event that might allow fetal blood cells to enter the mother’s system. The injection has been standard care for over half a century, and in countries with functioning prenatal care systems, severe hemolytic disease from Rh incompatibility has become rare.
When Prevention Fails or Is Unavailable
The reason Rh incompatibility still matters is that not every pregnancy is monitored. In areas with limited access to prenatal care, Rh-negative women may go through multiple pregnancies without ever receiving Rh immunoglobulin, building stronger antibody responses with each Rh-positive baby. Even in well-resourced settings, sensitization occasionally happens if a dose is missed or if a large enough bleed occurs before the injection can take effect.
When an already-sensitized mother is carrying an affected baby, the main treatment is intrauterine transfusion, a procedure where compatible red blood cells are delivered directly to the fetus through the umbilical cord under ultrasound guidance. A center in Belgium reported no perinatal deaths from the procedure over 14 years of experience, though complications were more common when the fetus already had severe fluid accumulation, making early detection and timely referral critical.3PubMed Central. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven Intrauterine transfusion requires specialized training and equipment, which limits its availability in many parts of the world.
What About ABO Incompatibility?
People sometimes worry that certain ABO blood type pairings, like a type O mother with a type A or B baby, could cause similar problems. ABO incompatibility does exist, and it can occasionally cause mild hemolytic disease in newborns. But it behaves very differently from Rh disease. The antibodies involved are usually a type that does not cross the placenta as aggressively, and the resulting anemia tends to be mild, often just requiring phototherapy for jaundice. ABO incompatibility does not worsen with subsequent pregnancies the way Rh disease can.
A case report documented hemolytic disease in a newborn from a less common ABO pairing, a type B mother and a type A baby, which was managed with phototherapy alone.4Europe PMC. Hemolytic Disease of Newborn due to ABO Incompatibility between B Blood Group Mother and A Blood Group Neonate This illustrates that while ABO mismatches can cause symptoms, they are typically manageable and rarely dangerous. No doctor would advise a couple against marrying because of their ABO types.
Beyond ABO and Rh: The Kell System and Other Antigens
The blood group systems most people know about, ABO and Rh, are just two of over 40 recognized blood group systems. Several others can, in rare cases, cause problems during pregnancy if the mother develops antibodies against antigens she lacks. The most clinically significant after Rh D is the Kell antigen. Kell-related hemolytic disease occurs in about 0.1 to 0.3 percent of pregnancies and accounts for roughly 10 percent of cases where antibodies cause severe fetal anemia.5PubMed Central. Approach to Pregnancy Affected by Kell Alloimmunization Kell disease is particularly tricky because the antibodies can suppress the baby’s red blood cell production in addition to destroying existing cells, making it harder to predict severity from standard monitoring alone.
Other minor blood group antigens, including those in the MNS system, can also rarely cause fetal anemia. A case report described a baby who needed multiple intrauterine transfusions due to anti-M antibodies, with hemoglobin measured at a critically low level at initial diagnosis, ultimately requiring a cesarean delivery at 34 weeks and additional transfusions after birth.6PubMed Central. Serial intrauterine transfusion for severe fetal anemia due to anti-M alloimmunization These cases are rare enough that routine screening for minor blood group antigens before marriage would not be practical for most populations. They do highlight, though, that blood group compatibility is more complicated than the simple charts passed around on social media.
The Real Concern People Confuse With Blood Type: Sickle Cell and Thalassemia
Much of the anxiety about “blood groups and marriage” actually comes from a different issue entirely: hemoglobin genotype. In many parts of Africa, the Middle East, and South Asia, premarital screening programs focus on whether both partners carry the sickle cell trait (AS genotype) or thalassemia trait. If two carriers marry and have children, each pregnancy carries a one-in-four chance of producing a child with sickle cell disease or thalassemia major, both of which cause chronic, serious illness. This is a genetic inheritance issue, not a blood group compatibility issue, but the two get muddled together constantly in everyday conversation.
The distinction matters. Your blood group (A, B, AB, O, Rh-positive or Rh-negative) is determined by surface antigens on your red blood cells and affects transfusion compatibility and pregnancy antibody reactions. Your hemoglobin genotype (AA, AS, SS, AC, and so on) is about the structure of the hemoglobin molecule inside those cells and determines whether you are at risk for sickle cell disease. A person can be type O-positive and have the AS genotype, or type AB-negative and be AA. The two systems are independent.
In Africa, a systematic review found that the pooled uptake of premarital sickle cell trait screening was about 48 percent, and that greater awareness of the disease was strongly linked to higher rates of screening.7BMC Public Health. Update on the practice of premarital screening for sickle cell traits in Africa: a systematic review and meta-analysis When people say “AS and AS should not marry,” they are talking about this hemoglobin genotype issue, not blood type. The advice has a solid medical basis: two carriers each passing the S gene to a child can produce sickle cell disease, which causes painful crises, organ damage, and shortened lifespan without aggressive treatment. But framing it as a “blood group” problem confuses the science and can lead people to make wrong assumptions about what tests they need.
Premarital Screening Programs and Their Impact
Several countries have made premarital screening mandatory, particularly in regions where sickle cell disease and thalassemia are common. Saudi Arabia launched a national program in 2004 that tests couples for sickle cell trait and beta-thalassemia trait before marriage. Over the first six years, the frequency of at-risk couples (where both partners were carriers) dropped by about 60 percent, and the rate of voluntary cancellation of marriage plans among at-risk couples rose more than fivefold, from about 9 percent to nearly 52 percent.8PubMed Central. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia
The economic argument is also substantial. A cost analysis of sickle cell screening in Saudi Arabia estimated that the annual cost of managing children born with sickle cell disease was roughly four times higher in a scenario without screening compared to one with screening, representing an approximate 73 percent reduction in healthcare spending when at-risk couples are identified and counseled before marriage.9PubMed Central. The Economic Impact of Premarital Screening (PMS) of Sickle Cell Anemia on the Saudi Health System: A Cost Analysis Study Researchers studying blood group phenotyping in Nigerian pregnant women have also recommended incorporating broader antigen screening into premarital testing to reduce the risk of antibody-related complications.10African Journal of Laboratory Haematology and Transfusion Science. ABO, Rh, and Kell Blood Group Antigen Frequencies among Pregnant Women in Sokoto, Nigeria
These programs are genuinely effective public health tools, but they work through counseling and informed decision-making, not by banning marriages. Even in Saudi Arabia, where screening is mandatory, the final decision rests with the couple. The program provides genetic counseling and information about the risks; it does not legally prevent anyone from marrying.
Consanguinity Adds Another Layer
In populations where marriages between relatives are common, rare blood disorders and other genetic conditions appear at higher rates. When closely related people have children, both parents are more likely to carry the same recessive genetic mutations inherited from a shared ancestor, increasing the odds that a child will receive two copies and develop the disease. A review of consanguineous marriage in Saudi Arabia found this pattern linked to elevated rates of congenital heart disease, kidney disorders, and rare blood disorders.11PubMed Central. Consanguineous Marriage and Its Association With Genetic Disorders in Saudi Arabia: A Review This is a broader genetic concern that extends far beyond blood type compatibility, but it feeds into the same cultural conversation about which marriages are medically “safe.”
Modern Diagnostic Tools
For Rh-negative women specifically, advances in prenatal testing have made risk management more precise. A technique called cell-free fetal DNA testing can determine the baby’s Rh status from a simple blood draw from the mother, without any invasive procedure. A meta-analysis covering over 11,000 samples found this test had a sensitivity of 99 percent and specificity of 98 percent, with first-trimester testing showing the highest accuracy.12PubMed. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis This means that many Rh-negative women carrying Rh-negative babies, who face no risk of sensitization at all, can be identified early and spared unnecessary Rh immunoglobulin injections. In several European countries, this test is already part of routine prenatal care.
The ability to test fetal blood type noninvasively in the first trimester has shifted the conversation further away from any notion that Rh-negative women should avoid Rh-positive partners. The medical system can now identify which pregnancies need intervention and which do not, making the pairing a matter of routine monitoring rather than a reason for alarm.
Why the Rh-Negative Trait Persists at All
If being Rh-negative creates a reproductive disadvantage through hemolytic disease, you might wonder why the trait has not been eliminated by natural selection over thousands of generations. A study investigating this question found strong support for the idea that Rh D polymorphism is maintained through heterozygote advantage, meaning people who carry one copy of the Rh-negative gene and one copy of the Rh-positive gene may have a survival or reproductive edge that keeps both versions circulating in the population.13PubMed. The role of balancing selection in maintaining human RhD blood group polymorphism A similar pattern of balancing selection has been proposed for ABO blood group variation, potentially driven by co-evolution with gut pathogens that exert different pressures on people with different blood types.14PubMed Central. Ancestry runs deeper than blood: the evolutionary history of ABO points to cryptic variation of functional importance
In other words, the very blood group differences that create occasional complications in pregnancy appear to have been preserved because they confer other advantages, likely related to disease resistance. This is an active area of research, and the specific mechanisms are still being worked out, but it underscores the point that blood group diversity is not a design flaw to be screened out of the marriage pool.
Rare Phenotypes and Transfusion Challenges
There are extremely rare blood phenotypes, like the Bombay and para-Bombay types, where a person lacks antigens found in virtually everyone else. People with the Bombay phenotype lack the H antigen that serves as a precursor to A and B antigens, so their blood is incompatible with all standard ABO types for transfusion purposes. A genetic study of the para-Bombay phenotype identified specific mutations in the gene responsible for producing the H antigen, with the affected enzyme showing no detectable activity.15PubMed. Two missense mutations of H type alpha(1,2)fucosyltransferase gene (FUT1) responsible for para-Bombay phenotype These individuals can generally only receive blood from other people with the same phenotype, which creates practical challenges in emergency medical situations. However, even these extreme cases do not constitute a medical reason to avoid marriage with a partner of a different blood type. The concern is about the individual’s own transfusion needs, not about offspring compatibility.
What Premarital Blood Testing Actually Tells You
If you and your partner are considering premarital blood tests, here is what is genuinely useful and what is not:
- Hemoglobin genotype: If both of you carry the sickle cell trait (AS) or thalassemia trait, each child has a 25 percent chance of inheriting the disease. This is the pairing that public health programs most urgently want you to know about.
- Rh factor: If you are Rh-negative and your partner is Rh-positive, your pregnancies will need Rh immunoglobulin injections. This is routine and highly effective, not a reason to cancel a wedding.
- ABO type: Knowing your ABO types is useful for medical records and emergency transfusions but tells you almost nothing about pregnancy risk that changes your decision-making.
- Kell and other minor antigens: Routine screening is not standard in most countries, but if you have a history of transfusions or complicated pregnancies, expanded antibody screening may be recommended.
The bottom line is straightforward: hemoglobin genotype compatibility is the screening that genuinely changes reproductive planning. Blood group typing is useful medical information that guides prenatal care but does not make any two people incompatible for marriage. The persistent myth that certain blood groups “cannot marry” conflates a manageable antibody issue with an unrelated and more serious genetic inheritance question, and in doing so, creates unnecessary fear for millions of couples.